A review of intranasal ketorolac tromethamine for the short-term management of moderate to moderately severe pain that requires analgesia at the opioid level

  title={A review of intranasal ketorolac tromethamine for the short-term management of moderate to moderately severe pain that requires analgesia at the opioid level},
  author={Andy He and Elliot V. Hersh},
  journal={Current Medical Research and Opinion},
  pages={1873 - 1880}
  • Andy He, E. Hersh
  • Published 26 October 2012
  • Medicine
  • Current Medical Research and Opinion
Abstract Background: An intranasal (IN) formulation of ketorolac was recently FDA approved in adult patients for the short-term management of moderate to moderately severe pain that requires analgesia at the opioid level. Scope: The aim of this paper is to provide an overview of the clinical pharmacology, pharmacokinetics, efficacy, and tolerability of IN ketorolac. Databases used for this literature search include PubMed, International Pharmaceutical Abstracts, Cochrane Library and… 
Comparison of analgesic effects of intravenous and intranasal ketorolac in patients with mandibular fracture-A Randomized Clinical Trial
Application of intranasal ketorolac spray decreased pain after mandibular fracture surgery, especially at 8-hour interval after surgery, decreasing the need for opioids.
Ketorolac Tromethamine – Routes and Clinical Implications
This review evaluates both the potential benefits and potential drawbacks of ketorolac generally, and specifically discusses routes of administration, including their advantages and disadvantages when compared to several traditional analgesics in both inpatient and outpatient settings.
Recent advances in the pharmacological management of acute and chronic pain.
Recent advances in the pharmacological management of pain are not so much the result of new 'miracle' drugs, but new preparations and new ways to use old drugs in a variety of settings, often as components of a multimodal approach to pain relief.
Nonopioid analgesics for postoperative pain management
Nonopioid analgesics are important components of multimodal postoperative analgesia and the selection of the most appropriate compound for an individual patient can be based more and more on ever increasing data on these important analgesics.
The Use of NSAIDs in the Postoperative Period: Advantage and Disadvantages
The concept of multimodal contest-sensible analgesia is now well accepted for the treatment of postoperative pain and different classes of analgesics are more effective than a single drug because of different mechanisms of action.
Nasal delivery of analgesic ketorolac tromethamine thermo- and ion-sensitive in situ hydrogels.
Enhancement in bioavailability of ketorolac tromethamine via intranasal in situ hydrogel based on poloxamer 407 and carrageenan.
The Various Functions of Opioids in Pathophysiological Conditions
The main purpose of this chapter is to update recent research on opioids and their various functions, particularly in pathophysiological conditions, and deliver an informative reference for better understanding the opioid system from a/the pathophysiology point of view.
Adjuvant Medications for Pain in the Rehabilitation Patient
This chapter will cover adjuvant, non-opioid medications used for pain management in the rehabilitation patient. This chapter is exclusive of opioids and psychiatric drugs usedfor pain, which are
Physical characterization and kinetic modelling of matrix tablets of ketorolac tromethamol formulated with polymers and waxes
Purpose: To design controlled release ketorolac tromethamol (KT) matrix tablets for increased drug bioavailability. Methods: Waxes (Compritol ® ATO 888, Precirol ® ATO 5 and stearic acid - SA) and


The Safety and Analgesic Efficacy of Intranasal Ketorolac in Patients with Postoperative Pain
Thirty milligrams of intranasal ketorolac demonstrated significant analgesic efficacy compared to 10 mg of intrastate ketorlac and placebo in patients undergoing major surgery.
Ketorolac. A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management.
Ketorolac is a strong analgesic with a tolerability profile which resembles that of other NSAIDs when used in accordance with current dosage guidelines, this drug provides a useful alternative, or adjuvant, to opioids in patients with moderate to severe pain.
Intranasal ketorolac for postoperative pain: a phase 3, double-blind, randomized study.
In ketorolac was well tolerated and effective in treating moderate-to-severe postoperative pain in inpatients; the convenience of IN dosing suggests that its usefulness in the ambulatory care setting should be evaluated.
Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review.
Parenteral ketorolac and risk of gastrointestinal and operative site bleeding. A postmarketing surveillance study.
The overall associations between ketorolac use and both gastrointestinal bleeding and operative site bleeding are small, however, the risk associated with the drug is larger and clinically important when ket orolac is used in higher doses, in older subjects, and for more than 5 days.
Intranasal ketorolac for pain secondary to third molar impaction surgery: a randomized, double-blind, placebo-controlled trial.
  • G. Grant, D. Mehlisch
  • Medicine
    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons
  • 2010
Pharmacokinetics and Safety of Ketorolac Following Single Intranasal and Intramuscular Administration in Healthy Volunteers
In ketorolac offers a therapeutic alternative to IM administration and may provide benefits in the clinical setting and dose proportionality was noted between the 15‐ and 30‐mg IN and IM dose levels.
A Novel Formulation of Ketorolac Tromethamine for Intranasal Administration
Local tolerance and systemic toxicology studies were performed in rats and rabbits and showed that intranasal administration of SPRIX exhibits toxicity similar to that of other routes of administration and does not result in any adverse effects on the nasal passage and upper and lower respiratory system.
Intranasal ketorolac for acute postoperative pain
Intranasal ketorolac was well tolerated and provided effective pain relief within 20 minutes with reduced opioid analgesia use and may have more relevance for use in outpatient settings and ambulatory surgery or fast-track surgical procedures.
The Effect of Intravenous Ketorolac on Opioid Requirement and Pain After Cesarean Delivery
IV ketorolac, as an adjunct to PCEA after cesarean delivery, produced a meperidine dose-sparing effect of approximately 30%, but did not significantly improve pain relief, reduce opioid-related side effects, or change patient outcome.